Ozempic is no longer just a diabetes drug or a weight-loss trend. It’s the centerpiece of a growing $157 billion market. Behind the scenes, a global patent race is quietly reshaping the future of metabolic health. The question now isn’t just who’s prescribing it, but who’s securing the rights to what comes next.
Download our most-shared infographic: https://bit.ly/3SiqHAK
#patseer #patents #patentlandscape #PatentPortfolio #patentsearchai #aipatentsearch #AI #intellectualproperty #Patentanalysis #patentdatabase #PatentAnalytics #ozempic #semaglutide #weightloss #PharmaIndustry #PharmaInnovation
Comments